Credit Suisse’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $8.32M | Buy |
|
|||||
|
2023
Q4 | $7.68M | Sell |
|
|||||
|
2023
Q3 | $2.59M | Buy |
|
|||||
|
2023
Q2 | $2.83M | Buy |
|
|||||
|
2023
Q1 | $1.62M | Buy |
|
|||||
|
2022
Q4 | $3.5M | Sell |
|
|||||
|
2022
Q3 | $3.47M | Buy |
|
|||||
|
2022
Q2 | $2.56M | Buy |
|
|||||
|
2022
Q1 | $2.57M | Buy |
|
|||||
|
2021
Q4 | $2.62M | Buy |
|
|||||
|
2021
Q3 | $3.81M | Buy |
|
|||||
|
2021
Q2 | $2.54M | Sell |
|
|||||
|
2021
Q1 | $4.32M | Buy |
|
|||||
|
2020
Q4 | $2.15M | Buy |
|
|||||
|
2020
Q3 | $246K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $99K | Sell |
|
|||||
|
2019
Q4 | $480K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $41K | Sell |
|
|||||
|
2018
Q1 | $84K | Buy |
|
|||||
|
2017
Q4 | $60K | Sell |
|
|||||
|
2017
Q3 | $142K | Buy |
|
|||||
|
2017
Q2 | $145K | Buy |
|
|||||
|
2017
Q1 | $54K | Sell |
|
|||||
|
2016
Q4 | $142K | Sell |
|
|||||
|
2016
Q3 | $204K | Sell |
|
|||||
|
2016
Q2 | $250K | Buy |
|
|||||
|
2016
Q1 | $127K | Buy |
|
|||||
|
2015
Q4 | $236K | Buy |
|
|||||
|
2015
Q3 | $125K | Buy |
|